At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 enrolled
Drug / intervention
Diazepam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intravaginal Diazepam for the Treatment of Pelvic Pain Among Women With Pelvic Floor Hypertonic Disorder: a Double Blind, Randomized, Placebo Controlled Trial
In Brief
A Phase 2 clinical trial evaluating Diazepam and Placebo for Pelvic Floor Disorders and Pelvic Pain. Completed, enrolled 50 participants across 1 site.
Detailed Summary
To determine the efficacy of intravaginal diazepam for the treatment of pelvic pain associated with pelvic floor hypertonic disorder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPelvic Floor Disorders, Pelvic Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedSep 2013
Primary CompletionMar 2017
Study CompletionJul 2017
TodayJul 2026
First PostedSep 10, 2013
Enrollment StartSep 1, 2013
Primary CompletionMar 1, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 12.8 years ago
Interventions
Diazepamdrug
Placebodrug